Lusutrombopag for Thrombocytopenia in Patients With Chronic Liver Disease Undergoing Invasive Procedures: A Systematic Review and Meta-analysis

Am J Ther. 2022 Sep-Oct;29(5):e599-e603. doi: 10.1097/MJT.0000000000001356. Epub 2021 Jun 30.

Authors

Azizullah Beran¹, Sami Ghazaleh¹, Mohammed Mhanna¹, Omar Srour¹, Justin Chuang¹, Mohammad Shaear², Yasir Al-Abboodi³, Ali Nawras³, Ragheb Assaly⁴

Affiliations

¹ Department of Internal Medicine, University of Toledo, Toledo, OH.
² Department of Surgery, Montefiore Medical Center, Bronx, NY.
³ Departments of Gastroenterology and Hepatology and.
⁴ Pulmonary and Critical Care Medicine, University of Toledo, Toledo, OH.

PMID: 36074991
DOI: 10.1097/MJT.0000000000001356

No abstract available

Publication types

Meta-Analysis
Systematic Review

MeSH terms

Chronic Disease
Cinnamates
Humans
Liver Diseases* / complications
Thiazoles / adverse effects
Thrombocytopenia*

Substances

Cinnamates
Thiazoles
lusutrombopag